undefined
Add a bookmark to get started
DLA Piper advises Akoya Biosciences in its business combination with Quanterix
13 January 2025 .1 minute read
DLA Piper advises the underwriters on a US$115 million public offering of common stock for...
12 December 2024 .1 minute read
DLA Piper advises the underwriters on a US$108 million public offering of common stock for...
20 November 2024 .2 minute read